- Home
- » Tags
- » Trifarotene
Top View
- Medicaid List of Covered Drugs (Formulary)
- Other Review(S)
- NDA Multidisciplinary Review and Evaluation
- Abstract Journal
- Trifarotene (Aklief) Reference Number: CP.PMN.225 Effective Date: 03.01.20 Last Review Date: 02.20 Line of Business: Commercial, HIM, Medicaid Revision Log
- FEP 5 Tier Rx Drug Formulary (607) Standard Option
- CP.PMN.225 Trifarotene (Aklief)
- 2021 Aetna Premier Plan
- Topical Azelaic Acid Products
- (PA) Cross Reference
- Aars Hot Topics Member Newsletter
- Topical Acne and Rosacea Agents NOTICE
- Appendix a - Product Name Index
- Trifarotene) Cream, for Topical Use Experienced with Use of AKLIEF Cream
- Mayne Pharma Group Limited FY17 Results Presentation 25 August 2017
- POS Formulary with Specialty Drug Tier
- Foray Into Concepts of Design and Evaluation of Microemulsions As a Modern Approach for Topical Applications in Acne Pathology
- Orange Book Cumulative Supplement 7 July 2021
- Long‐Term Safety and Efficacy of Trifarotene 50 Μg/G Cream, a First‐In
- MEDICAL DERMATOLOGY Previous Page | Contents | Zoom in | Zoom8.25” out | Search Issue | Cover | Next Page
- FEP 5 Tier Managed Rx Drug Formulary (807) Basic Option
- Non-Preferred Drug List (NPDL)
- Trifarotene: a Current Review and Perspectives in Dermatology
- Acne & Rosacea
- New Directions in Acne Care Recent Developments and Therapeutic Advancements Continue to Improve Outcomes in the Management of This Common, Inflammatory Disease
- VIRGINIA PREMIER MEDALLION 4.0 PRIOR AUTHORIZATION DETAIL September 1, 2021
- Topical Retinoid Products All Brand and Generic Tretinoin-, Adapalene
- Why We Should Consider Evidence-Based Treatment Options for Truncal Acne
- Drug Class Update with New Drug Evaluation: Acne Drugs
- Australian Public Assessment Report for Trifarotene
- Topical Trifarotene
- Treating Acne
- TRETINOIN Aklief (Trifarotene), Altreno (Tretinoin), Atralin (Tretinoin), Avita